Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(6):366–369. doi: 10.1155/S1064744997000665

The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity

C D Adair 1,✉, J W Weeks 1, G Johnson 1, S Burlison 1, S London 1, D F Lewis 1
PMCID: PMC2364586  PMID: 18476189

Abstract

Objectives: To evaluate the utility of intrapartum amnioinfusion (AI) in reducing the infectious morbidity of patients with meconium-stained fluid (MSF). Previous studies have shown increased intraamniotic infection (IAI) and postpartum endometritis (PPE) rates in patients with MSF. Intraamniotic infection has been reduced with the prophylactic administration of ampicillin–sulbactam in MSF. Intraamniotic infection and PPE have been reduced with the use of AI in patients with clear fluid. No investigators have specifically examined the efficacy of AI in reducing meconium-stained, amniotic-fluid-associated infectious morbidity.

Methods: A retrospective cohort study of all cases of MSF was conducted and included patients who delivered at Louisiana State University Medical Center–Shreveport during the one-year period from January to December 1996. Patients were identified from the perinatal database by the diagnosis code of MSF. The medical records were reviewed to determine the consistency of MSF and the presence or absence of infectious morbidity. Patient demographics, labor characteristics, and various risk factors for infection were sought. The main outcome measures were the occurrence of clinical IAI or PPE. Statistical analysis included two-tailed unpaired t-test, X2, ANOVA, and Fisher exact test when appropriate.

Results: Two hundred seventy-three medical records of patients with MSF were studied. One hundred twenty nine patients received AI, and 144 did not receive AI. No significant differences in demographics, labor characteristics, or outcome variables were noted between the two groups. The incidences of IAI were 18.6% and 24.3%, P = 0.13, in the AI and non-AI groups, respectively. Postpartum endometritis occurred in 22.5% of AI patients and 21.5% of non-AI patients, P = 0.97.

Conclusions: The use of AI confers no benefit for the reduction of infectious morbidity in patients with MSF.

Full Text

The Full Text of this article is available as a PDF (324.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adair C. D., Ernest J. M., Sanchez-Ramos L., Burrus D. R., Boles M. L., Veille J. C. Meconium-stained amniotic fluid-associated infectious morbidity: a randomized, double-blind trial of ampicillin-sulbactam prophylaxis. Obstet Gynecol. 1996 Aug;88(2):216–220. doi: 10.1016/0029-7844(96)00148-2. [DOI] [PubMed] [Google Scholar]
  2. Blot P., Milliez J., Breart G., Vige P., Nessmann C., Onufryk J. P., Dendrinos S., Sureau C. Fetal tachycardia and meconium staining: a sign of fetal infection. Int J Gynaecol Obstet. 1983 Jun;21(3):189–194. doi: 10.1016/0020-7292(83)90078-4. [DOI] [PubMed] [Google Scholar]
  3. Chapman S., Duff P. Incidence of chorioamnionitis in patients with meconium-stained amniotic fluid. Infect Dis Obstet Gynecol. 1995;2(5):210–212. doi: 10.1155/S1064744995000032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clark P., Duff P. Inhibition of neutrophil oxidative burst and phagocytosis by meconium. Am J Obstet Gynecol. 1995 Oct;173(4):1301–1305. doi: 10.1016/0002-9378(95)91375-0. [DOI] [PubMed] [Google Scholar]
  5. Florman A. L., Teubner D. Enhancement of bacterial growth in amniotic fluid by meconium. J Pediatr. 1969 Jan;74(1):111–114. doi: 10.1016/s0022-3476(69)80016-8. [DOI] [PubMed] [Google Scholar]
  6. Gibbs R. S., Blanco J. D., Hnilica V. S. Inorganic phosphorus and zinc concentrations in amniotic fluid: correlation with intra-amniotic infection and bacterial inhibitory activity. Am J Obstet Gynecol. 1982 May 15;143(2):163–166. doi: 10.1016/0002-9378(82)90647-0. [DOI] [PubMed] [Google Scholar]
  7. Gregory G. A., Gooding C. A., Phibbs R. H., Tooley W. H. Meconium aspiration in infants--a prospective study. J Pediatr. 1974 Dec;85(6):848–852. doi: 10.1016/s0022-3476(74)80358-6. [DOI] [PubMed] [Google Scholar]
  8. Hoskins I. A., Hemming V. G., Johnson T. R., Winkel C. A. Effects of alterations of zinc-to-phosphorus ratios and meconium content on group B Streptococcus growth in human amniotic fluid in vitro. Am J Obstet Gynecol. 1987 Sep;157(3):770–773. doi: 10.1016/s0002-9378(87)80047-9. [DOI] [PubMed] [Google Scholar]
  9. Macri C. J., Schrimmer D. B., Leung A., Greenspoon J. S., Paul R. H. Prophylactic amnioinfusion improves outcome of pregnancy complicated by thick meconium and oligohydramnios. Am J Obstet Gynecol. 1992 Jul;167(1):117–121. doi: 10.1016/s0002-9378(11)91641-x. [DOI] [PubMed] [Google Scholar]
  10. Mazor M., Furman B., Wiznitzer A., Shoham-Vardi I., Cohen J., Ghezzi F. Maternal and perinatal outcome of patients with preterm labor and meconium-stained amniotic fluid. Obstet Gynecol. 1995 Nov;86(5):830–833. doi: 10.1016/0029-7844(95)00265-S. [DOI] [PubMed] [Google Scholar]
  11. Meis P. J., Hall M., 3rd, Marshall J. R., Hobel C. J. Meconium passage: a new classification for risk assessment during labor. Am J Obstet Gynecol. 1978 Jul 1;131(5):509–513. doi: 10.1016/0002-9378(78)90111-4. [DOI] [PubMed] [Google Scholar]
  12. Miyazaki F. S., Nevarez F. Saline amnioinfusion for relief of repetitive variable decelerations: a prospective randomized study. Am J Obstet Gynecol. 1985 Oct 1;153(3):301–306. doi: 10.1016/s0002-9378(85)80116-2. [DOI] [PubMed] [Google Scholar]
  13. Miyazaki F. S., Taylor N. A. Saline amnioinfusion for relief of variable or prolonged decelerations. A preliminary report. Am J Obstet Gynecol. 1983 Jul 15;146(6):670–678. doi: 10.1016/0002-9378(83)91010-4. [DOI] [PubMed] [Google Scholar]
  14. Moen M. D., Besinger R. E., Tomich P. G., Fisher S. G. Effect of amnioinfusion on the incidence of postpartum endometritis in patients undergoing cesarean delivery. J Reprod Med. 1995 May;40(5):383–386. [PubMed] [Google Scholar]
  15. Monahan E., Katz V. L., Cox R. L. Amnioinfusion for preventing puerperal infection. A prospective study. J Reprod Med. 1995 Oct;40(10):721–723. [PubMed] [Google Scholar]
  16. Romero R., Hanaoka S., Mazor M., Athanassiadis A. P., Callahan R., Hsu Y. C., Avila C., Nores J., Jimenez C. Meconium-stained amniotic fluid: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol. 1991 Mar;164(3):859–862. doi: 10.1016/0002-9378(91)90529-z. [DOI] [PubMed] [Google Scholar]
  17. Sadovsky Y., Amon E., Bade M. E., Petrie R. H. Prophylactic amnioinfusion during labor complicated by meconium: a preliminary report. Am J Obstet Gynecol. 1989 Sep;161(3):613–617. doi: 10.1016/0002-9378(89)90364-5. [DOI] [PubMed] [Google Scholar]
  18. Steer P. J., Eigbe F., Lissauer T. J., Beard R. W. Interrelationships among abnormal cardiotocograms in labor, meconium staining of the amniotic fluid, arterial cord blood pH, and Apgar scores. Obstet Gynecol. 1989 Nov;74(5):715–721. [PubMed] [Google Scholar]
  19. Wen T. S., Eriksen N. L., Blanco J. D., Graham J. M., Oshiro B. T., Prieto J. A. Association of clinical intra-amniotic infection and meconium. Am J Perinatol. 1993 Nov;10(6):438–440. doi: 10.1055/s-2007-994625. [DOI] [PubMed] [Google Scholar]
  20. Wenstrom K. D., Parsons M. T. The prevention of meconium aspiration in labor using amnioinfusion. Obstet Gynecol. 1989 Apr;73(4):647–651. [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES